Health Care & Life Sciences » Biotechnology | Lexicon Pharmaceuticals Inc.

Lexicon Pharmaceuticals Inc.

Lexicon Pharmaceuticals Inc.
Stock Exchange Frankfurt Stock Exchange
EPS
-
Market Cap
-
Shares Outstanding
105.88 M
Public Float
22.55 M
Lexicon Pharmaceuticals Inc.
Stock Exchange NASDAQ Stock Market
EPS
$0.95
Market Cap
$668.45 M
Shares Outstanding
106.27 M
Public Float
102.99 M

Profile

Address
8800 Technology Forest Place
The Woodlands Texas 77381
United States
Employees -
Website http://www.lexpharma.com
Updated 07/08/2019
Lexicon Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of pharmaceutical products for the treatment of human disease. It also offers programs in clinical development for diabetes, irritable bowel syndrome, and carcinoid syndrome. The company was founded by Brian P.

Financials

View All

Lonnel Coats
President, Chief Executive Officer & Director
Raymond Debbane
Chairman